Status:
COMPLETED
Effect of Limicol on (LDL)-Cholesterol Levels in Moderate Hypercholesterolaemia
Lead Sponsor:
Lescuyer Laboratory
Collaborating Sponsors:
BioFortis
Conditions:
Delivery of Health Care
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to validate the effectiveness of food supplement Limicol on reducing LDL-cholesterol in moderate hypercholesterolemic volunteers.
Detailed Description
Cardiovascular disease (CVD), foremost among which ischemic heart disease and stroke, are the leading cause of mortality and morbidity in France. These diseases are multifactorial origin and even if i...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- About 18 to 65 years (inclusive).
- Subject has a stable weight for at least three months before the start of the study.
- Subject able and willing to comply with the protocol and agreeing to give their consent in writing.
- Subject affiliated with a social security scheme.
- Subject willing to be included in the national register of volunteers who lend themselves to biomedical research.
Exclusion
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01139398
Start Date
May 1 2010
End Date
January 1 2012
Last Update
February 22 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biofortis
Nantes, France, 44200